Quantification of oxyresveratrol analog trans-2,4,3',5'-tetramethoxystilbene in rat plasma by a rapid HPLC method: Application in a pre-clinical pharmacokinetic study

Biomedical Chromatography

Volumn 24, Issue 12, 2010, Pages 1373-1378

  Lin, Hai Shu ^a   Choo, Qiu Yi ^a   Ho, Paul C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Absolute oral bioavailability; HPLC; Oxyresveratrol; Pharmacokinetics; Resveratrol; trans 2,4,3',5' tetramethoxystilbene

Indexed keywords

BIOCHEMISTRY; BODY FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RATS; RESVERATROL;

ABSOLUTE ORAL BIOAVAILABILITY; HPLC; HPLC METHOD; ORAL ADMINISTRATION; ORAL BIOAVAILABILITIES; OXYRESVERATROL; PRE-CLINICAL; RAT PLASMA; TETRAMETHYL; TRANS-2,4,3',5'-TETRAMETHOXYSTILBENE;

PHARMACOKINETICS;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2,4,3',5' TETRAMETHOXYSTILBENE; ACETONITRILE; CYTOCHROME P450 1B1; OXYRESVERATROL TETRAMETHYL ETHER; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; STANDARD; ULTRAVIOLET RADIATION;

RATTUS;

EID: 78449233262     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1454     Document Type: Article

References (22)

1. Andrabi SA, Spina MG, Lorenz P, Ebmeyer U, Wolf G and Horn TF. Oxyresveratrol (trans-2, 3', 4, 5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Research 2004; 1017: 98-107.
2. Ban JY, Jeon SY, Nguyen TT, Bae K, Song KS and Seong YH. Neuroprotective effect of oxyresveratrol from smilacis chinae rhizome on amyloid beta protein (25-35)-induced neurotoxicity in cultured rat cortical neurons. Biological and Pharmaceutical Bulletin 2006; 29: 2419-2424.
3. Baur JA and Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery 2006; 5: 493-506.
4. Bertram RM, Takemoto JK, Remsberg CM, Vega-Villa KR, Sablani S and Davies NM. High-performance liquid chromatographic analysis: applications to nutraceutical content and urinary disposition of oxyresveratrol in rats. Biomedical Chromatography 2009.
5. Chao J, Yu MS, Ho YS, Wang M and Chang RC. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radical Biology and Medicine 2008; 45: 1019-1026.
6. Chun YJ, Kim S, Kim D, Lee SK and Guengerich FP. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Research 2001; 61: 8164-8170.
7. Chun YJ, Lee SK and Kim MY. Modulation of human cytochrome P450 1B1 expression by 2, 4, 3', 5'-tetramethoxystilbene. Drug Metabolism and Disposition 2005; 33: 1771-1776.
8. Chung KO, Kim BY, Lee MH, Kim YR, Chung HY, Park JH and Moon JO. In-vitro and in-vivo anti-inflammatory effect of oxyresveratrol from Morus alba L. Journal of Pharmacy and Pharmacology 2003; 55: 1695-1700.
9. Das S, Lin HS, Ho PC and Ng KY. The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharmaceutical Research 2008; 25: 2593-2600.
10. Huang H, Chen G, Lu Z, Zhang J and Guo DA. Identification of seven metabolites of oxyresveratrol in rat urine and bile using liquid chromatography/tandem mass spectrometry. Biomedical Chromatography 2009.
11. Kim S, Ko H, Park JE, Jung S, Lee SK and Chun YJ. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. Journal of Medicinal Chemistry 2002; 45: 160-164.
12. Kim SW, Jung HK and Kim MY. Induction of p27(kip1) by 2, 4, 3', 5' tetramethoxystilbene is regulated by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. Archives of Pharmacal Research 2008; 31: 1187-1194.
13. Lin HS and Ho PC. A rapid HPLC method for the quantification of 3, 5, 4' trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2009; 49: 387-392.
14. Lin HS, Leong WW, Yang JA, Lee P, Chan SY and Ho PC. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins. International Journal of Pharmaceutics 2007; 341: 238-245.
15. Lin HS, Yue BD and Ho PC. Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomedical Chromatography 2009; 23: 1308-1315.
16. Lin HS, Tringali C, Spatafora C, Wu C and Ho PC. A simple and sensitive HPLC-UV method for the quantification of piceatannol analog trans-3, 5, 3', 4'-tetramethoxystilbene in rat plasma and its application for a pre-clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 2010; 51: 679-684.
17. Lorenz P, Roychowdhury S, Engelmann M, Wolf G and Horn TF. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 2003; 9: 64-76.
18. Mouihate A, Horn TF and Pittman QJ. Oxyresveratrol dampens neuroimmune responses in vivo: a selective effect on TNF-alpha. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2006; 291: R1215-1221.
19. Nam KA, Kim S, Heo YH and Lee SK. Resveratrol analog, 3, 5, 2', 4'-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells. Archives of Pharmacal Research 2001; 24: 441-445.
20. Park H, Aiyar SE, Fan P, Wang J, Yue W, Okouneva T, Cox C, Jordan MA, Demers L, Cho H, Kim S, Song RX and Santen RJ. Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action. Cancer Research 2007; 67: 5717-5726.
21. Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM and Davies NM. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytotherapy Research 2008; 22: 169-179.
22. Roupe KA, Yanez JA, Teng XW and Davies NM. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. Journal of Pharmacy and Pharmacology 2006; 58: 1443-1450.